CHRONIC HEPATITIS C(CHC)
Clinical trials for CHRONIC HEPATITIS C(CHC) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS C(CHC) trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS C(CHC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to knock out hepatitis c virus
Disease control CompletedThis study tested whether a three-drug combination (MP-424, interferon beta, and ribavirin) could successfully control Hepatitis C virus in people with specific strains of the disease. It involved 74 patients who were either new to treatment or had tried previous interferon-based…
Matched conditions: CHRONIC HEPATITIS C(CHC)
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Apr 04, 2026 07:36 UTC
-
New triple therapy shows promise against hepatitis c
Disease control CompletedThis study tested whether adding an experimental drug called MP-424 to two standard hepatitis C medications could better control the virus. It involved 54 adults with a specific type of hepatitis C who had never been treated or whose previous treatment had stopped working. The ma…
Matched conditions: CHRONIC HEPATITIS C(CHC)
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC